ClinicalTrials.Veeva

Menu

Comparison of Osteoporosis Disease Management Strategies (0000-039)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status

Completed

Conditions

Osteoporosis

Treatments

Behavioral: Disease Management Assessment

Study type

Interventional

Funder types

Industry

Identifiers

NCT00145080
2005_050
0000-039
039

Details and patient eligibility

About

The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.

Enrollment

4,685 patients

Sex

Female

Ages

50 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Members of the Harvard Pilgrim Health Plan

Exclusion criteria

  • Individuals who are not members of the Harvard Pilgrim Health Plan

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems